Dosage, exposure timing and immune cell status affects immunomodulatory properties of platelet-rich plasma in knee osteoarthritis in vitro

Platelet-rich plasma (PRP) is an alternative treatment for knee osteoarthritis (OA) patients. However, studies have shown controversial results from using this blood-derived product. This may be due to the lack of in-depth understanding of the molecular mechanisms of PRP. Immunologically, PRP normally reduces inflammation, but have been shown to increase inflammation in high doses. Therefore, in our study, we evaluated the effects of PRP on monocytes and T cells, predominant immune cells in synovial fluid of knee joints exposed to PRP. Using a direct in vitro assessment approach, we tested on various conditions of PRP usage by evaluating PRP dosage, timing of PRP exposure, immune cell subpopulation phenotype after PRP exposure and the state of immune cells prior to exposure to PRP. We show that PRP effects immune cells differently depending on the parameter evaluated. Our results demonstrate in vitro conditions that affect outcome of PRP exposure, in which knee OA patients may benefit from optimizing PRP treatment conditions as well as precautions and limitations of PRP usage.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-13
DOI
https://doi.org/10.1038/s41598-026-75564-3
Primary Topic
Periodontal Regeneration and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Dosage, exposure timing and immune cell status affects immunomodulatory properties of platelet-rich plasma in knee osteoarthritis in vitro

Panjana Sengprasert, Nitigorn Leearamwat, Srihatach Ngarmukos, Rangsima Reantragoon et al.
2 links
Scientific Reports
Periodontal Regeneration and Treatments
article

Dosage, exposure timing and immune cell status affects immunomodulatory properties of platelet-rich plasma in knee osteoarthritis in vitro

Panjana Sengprasert, Nitigorn Leearamwat, Srihatach Ngarmukos, Rangsima Reantragoon, Aree Tanavalee, Patchanika Hengtrakool, Sujinthra Pimthanom
article en

Abstract

Platelet-rich plasma (PRP) is an alternative treatment for knee osteoarthritis (OA) patients. However, studies have shown controversial results from using this blood-derived product. This may be due to the lack of in-depth understanding of the molecular mechanisms of PRP. Immunologically, PRP normally reduces inflammation, but have been shown to increase inflammation in high doses. Therefore, in our study, we evaluated the effects of PRP on monocytes and T cells, predominant immune cells in synovial fluid of knee joints exposed to PRP. Using a direct in vitro assessment approach, we tested on various conditions of PRP usage by evaluating PRP dosage, timing of PRP exposure, immune cell subpopulation phenotype after PRP exposure and the state of immune cells prior to exposure to PRP. We show that PRP effects immune cells differently depending on the parameter evaluated. Our results demonstrate in vitro conditions that affect outcome of PRP exposure, in which knee OA patients may benefit from optimizing PRP treatment conditions as well as precautions and limitations of PRP usage.

Scientific Reports
Chulalongkorn University (TH), Bansomdejchaopraya Rajabhat University (TH)
Chulalongkorn University, Thailand Science Research and Innovation, Faculty of Medicine, Chulalongkorn University
Good health and well-being
Periodontal Regeneration and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon